Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 2/20 | 0.58 |
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | CSF1R | P07333 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31752932 | 0.89 | CHEK2 (0.57) | CHEK2GPR119SCN9ACSF1RKDR | |
| SCHEMBL31753503 | 0.89 | GPR119 (0.65) | CHEK2GPR119SCN9A | |
| SCHEMBL31752847 | 0.86 | CHEK2 (0.68) | CHEK2GPR119KDM4EPKM | |
| SCHEMBL1296310 | 0.85 | GPR119 (0.63) | CHEK2GPR119 | |
| SCHEMBL1295322 | 0.84 | GPR119 (0.61) | CHEK2GPR119 | |
| SCHEMBL1576144 | 0.84 | GPR119 (0.72) | CHEK2GPR119SCN9A | |
| SCHEMBL1646632 | 0.83 | GPR119 (0.59) | CHEK2GPR119SCN9ACSF1RKDR | |
| SCHEMBL31752692 | 0.82 | GPR119 (0.55) | CHEK2GPR119CSF1RKDR | |
| SCHEMBL3325497 | 0.81 | GPR119 (0.52) | CHEK2GPR119CSF1RKDM4EPKM | |
| SCHEMBL4140112 | 0.81 | GPR119 (0.71) | CHEK2GPR119SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262297-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |